Author:
Bartels Indra,Nahar Nazmun,Smollich Esther,Zimmermann Sonja,Schmidt Torsten C.,Jaeger Martin,Sures Bernd
Reference48 articles.
1. Molnupiravir: First Approval;Y Y Syed;Drugs,2022
2. Favipiravir, an anti-influenza drug against lifethreatening RNA virus infections;K Shiraki;Pharmacology & Therapeutics,2020
3. A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance;M Kumar;Journal of Hazardous Materials,2021
4. Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19;G R Painter;Current opinion in virology,2021